Consistent with the in vivo study, a 3D human NASH in vitro model further demonstrated that TSP1-deficient platelets have the potential to attenuate inflammation and fibrosis directly or indirectly through secreted factors to affect liver cell functions. This evidence concerns the gene THBS1 and metabolic dysfunction-associated steatohepatitis.